Page results
-
This page explains what autologous stem cell transplant is and includes information about our stem cell transplant service and process, the care patients will receive and what to expect after the transplant.
-
This information explains what alpha thalassaemia is, and provides information about the different types of alpha thalassaemia.
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
-
Information about community sickle cell and thalassaemia services provided via UCLH.
-
Mr Seni Subair specialises in pregnancy and labour care, medical disorders (including perinatal mental health) in pregnancy,
-
Mr Ruwan Wimalasundera is a senior consultant obstetrician and fetal medicine specialist at UCLH. He manages all aspects of pregnancy, including both low -risk and high-risk pregnancies, especially older mothers and multiple pregnancies
-
Professor Pandya is a consultant in fetal medicine at UCLH
-
This information is about penile cancer multidisciplinary team (MDT), the a team of professionals who will be caring for you at University College Hospital (UCLH).
-
Information about sickle cell disorder in adulthood for UCLH patients.
-
Over half a million non-sterile blue gloves have been saved from landfill since we launched our Gloves Off initiative in May last year.
File results
-
FOI/2022/0433 - A&E attendances with effects of heat, light and sunburn
-
FOI/2022/0437 - IT infrastructure systems used at Trust
-
FOI/2022/0443 - Trust spend on lost, stolen or damaged patient property
-
FOI/2022/0448 - Electronic cloud based job evaluation system
-
FOI/2022/0449 - Use of defibrotide for the treatment of Hepatic Veno-occlusive disease
-
FOI/2022/0451 - Patient information leaflets
-
FOI/2022/0454 - Temporary staff waiting list initiative and overtime spend
-
FOI/2022/0456 - Treatment of renal cell carcinoma
-
FOI/2022/0459 - Interpreters and translation services
-
FOI/2022/0465 - Treatment of dermatological conditions